Telo Genomics Corp - ESG Rating & Company Profile powered by AI
Scroll down to the end of the page for potential risks for Telo Genomics Corp based on industry, geography and size. If you are employed by Telo Genomics Corp and you wish to licence your ESG aseessment, please contact us. The ESG rating for Telo Genomics Corp indicates its reporting of the United Nations Sustainable Development Goals.
Telo Genomics Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.1; made up of an environmental score of 4.0, social score of 2.7 and governance score of 2.7.
3.1
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1299 | Active Fine Chemicals Ltd | 3.2 | Medium |
1299 | Yuhan Corp | 3.2 | Medium |
1309 | Telo Genomics Corp | 3.1 | Medium |
1309 | Champions Oncology Inc | 3.1 | Medium |
1309 | IBEX Technologies Inc | 3.1 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Telo Genomics Corp have an accelerator or VC vehicle to help deliver innovation?
Does Telo Genomics Corp disclose current and historical energy intensity?
Does Telo Genomics Corp report the average age of the workforce?
Does Telo Genomics Corp reference operational or capital allocation in relation to climate change?
Does Telo Genomics Corp disclose its ethnicity pay gap?
Does Telo Genomics Corp disclose cybersecurity risks?
Does Telo Genomics Corp offer flexible work?
Does Telo Genomics Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Telo Genomics Corp disclose the number of employees in R&D functions?
Does Telo Genomics Corp conduct supply chain audits?
Does Telo Genomics Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Telo Genomics Corp conduct 360 degree staff reviews?
Does Telo Genomics Corp disclose the individual responsible for D&I?
Does Telo Genomics Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Telo Genomics Corp disclose current and / or historical scope 2 emissions?
Does Telo Genomics Corp disclose water use targets?
Does Telo Genomics Corp have careers partnerships with academic institutions?
Did Telo Genomics Corp have a product recall in the last two years?
Does Telo Genomics Corp disclose incidents of discrimination?
Does Telo Genomics Corp allow for Work Councils/Collective Agreements to be formed?
Has Telo Genomics Corp issued a profit warning in the past 24 months?
Does Telo Genomics Corp disclose parental leave metrics?
Does Telo Genomics Corp disclose climate scenario or pathway analysis?
Does Telo Genomics Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Telo Genomics Corp disclose the pay ratio of women to men?
Does Telo Genomics Corp support suppliers with sustainability related research and development?
Does Telo Genomics Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Telo Genomics Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Telo Genomics Corp involved in embryonic stem cell research?
Does Telo Genomics Corp disclose GHG and Air Emissions intensity?
Does Telo Genomics Corp disclose its waste policy?
Does Telo Genomics Corp report according to TCFD requirements?
Does Telo Genomics Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Telo Genomics Corp disclose energy use targets?
Does Telo Genomics Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Telo Genomics Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Telo Genomics Corp
These potential risks are based on the size, segment and geographies of the company.
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada.